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Signal transducer and activator of transcription
(STAT) family members direct the differentiation of
T helper cells, with specific STAT proteins promoting
distinct effector subsets. STAT6 is required for the
development of T helper 2 (Th2) cells, whereas
STAT3 promotes differentiation of Th17 and follicular
helper T cell subsets. We demonstrated that STAT3
was also activated during Th2 cell development
andwas required for the expression of Th2 cell-asso-
ciated cytokines and transcription factors. STAT3
bound directly to Th2 cell-associated gene loci and
was required for the ability of STAT6 to bind target
genes. In vivo, STAT3 deficiency in T cells eliminated
the allergic inflammation in mice sensitized and
challenged with ovalbumin or transgenic for consti-
tutively active STAT6. Thus, STAT3 cooperates with
STAT6 in promoting Th2 cell development. These
results demonstrate that differentiating T helper
cells integrate multiple STAT protein signals during
Th2 cell development.
INTRODUCTION
CD4+ T helper cells differentiate into several distinct subsets
to provide host protection against a variety of pathogens. Each
T helper cell lineage expresses specific transcription factors
and cytokines that confer specific effector functions. T helper 2
(Th2) cells secrete interleukin (IL)-4, IL-5, and IL-13, which are
important for immunity against extracellular parasites and for
providing B cell help leading to antibody production. However,
nonprotective Th2 cell responses contribute to asthma, allergy,
and other allergic diseases (Zhu and Paul, 2008).
The differentiation of Th2 cells occurs when a naive T cell is
activated by antigen in the presence of IL-4. The IL-4 receptor
is composed of the common cytokine receptor gamma subunit
and the IL-4Ra chain. IL-4R is expressed at low levels on
the surface of naive CD4+ T cells, but upon antigen stimulation
IL-4R surface expression is increased. IL-4 binding to the
IL-4R results in recruitment of signal transducer and activatorof transcription 6 (STAT6). STAT6 then becomes phosphory-
lated, dimerizes, and translocates to the nucleus where it can
activate transcription of Th2 cell-specific genes (Nelms et al.,
1999).
There are several transcription factors associated with estab-
lishing the Th2 cell phenotype. STAT6 induces expression of
GATA3, which is considered the Th2 cell master regulator
(Ouyang et al., 2000). Other transcription factors important for
Th2 cell development are induced upon TCR stimulation
including NFAT family members, IRF4, Jun family members,
and c-MAF (Ansel et al., 2006; Lee et al., 2006; Murphy and
Reiner, 2002). More recently, BATF was suggested to play
a role in promoting the Th2 cell phenotype (Betz et al., 2010).
The expression of each transcription factor is necessary for
optimal Th2 cell development.
Though particular cytokines are thought to be promoters of
specific Th cell lineages, a differentiating Th cell receivesmultiple
cytokine signals. IL-4 and STAT6 clearly play a dominant role in
Th2 cell differentiation. Transgenic mice expressing IL-4 or
constitutively active STAT6 are characterized by the develop-
ment of spontaneous allergic inflammation (Sehra et al., 2008;
Tepper et al., 1990). Development of allergic disease is
completely dependent on IL-4 as shown by the fact that allergic
inflammation is diminished in mice deficient in IL-4 or STAT6
(Akimoto et al., 1998; Brusselle et al., 1995; Kuperman et al.,
1998; Sehra et al., 2008). However, IL-2 and STAT5 are also
necessary for optimal Th2 cell differentiation through direct
effects on Th2 cell cytokines and Il4ra expression (Ben-Sasson
et al., 1990; Cote-Sierra et al., 2004; Kagami et al., 2001; Liao
et al., 2008; Zhu et al., 2003). Moreover, although STAT3 is
required for the differentiation and effector function of both
Th17 and Tfh cells, IL-6-activated STAT3 promotesMaf expres-
sion, a factor required for IL-4 expression in Th2 cells (Mathur
et al., 2007; Nurieva et al., 2008; Yang et al., 2005, 2007).
STAT3 directly binds the Maf and Batf loci (Durant et al., 2010).
IL-6 also induces SOCS1 and NFATc2 that decrease Th1 cell
differentiation and increase IL-4 production, respectively, during
Th2 cell development (Diehl et al., 2000, 2002). However, the
requirement for STAT3 in Th2 cell development has not been
defined.
In this report we demonstrate that STAT3 is required for Th2
cytokine production and transcription factor expression.
STAT3 was activated throughout Th2 cell differentiation and
when ectopically expressed with STAT6 could augment Th2Immunity 34, 39–49, January 28, 2011 ª2011 Elsevier Inc. 39
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STAT3 in Th2 Cellscell cytokine production. STAT3 was also required for Th2 cell-
mediated allergic inflammation. Thus, in the presence of acti-
vated STAT6, STAT3 promotes optimal Th2 cell differentiation
and cytokine production.
RESULTS
STAT3 Is Activated during Th2 Cell Differentiation
STAT6 activation is critical in Th2 cell differentiation. Though
several cytokines important in Th2 cell differentiation and
cytokine production signal through STAT3, the activation
of STAT3 during Th2 cell development has not been carefully
examined. To define STAT3 activation throughout Th2 cell
differentiation, wild-type and STAT3-deficient Th2 cells were as-
sessed for intracellular phospho-STAT3 and phospho-STAT6
each day during Th2 cell differentiation. Wild-type Th2 cells
were nearly all phospho-STAT6 positive early on in differentiation
and remained phospho-STAT6 positive throughout differentia-
tion (Figures 1A and 1B). Wild-type Th2 cells also demonstrated
a high percentage of phospho-STAT3-positive cells throughout
Th2 cell differentiation. STAT3 phosphorylation occurred early
in differentiation, peaked at 48 hr, and decreased by 72 hr
(Figures 1A and 1B). There was a second peak of STAT3 phos-
phorylation after addition of further cytokines at 72 hr (Figures
1A and 1B). The initial induction of STAT3 phosphorylation was
independent of IL-4 signaling because it was identical between
wild-type and STAT6-deficient cells during the first 3 days of
Th2 cell cultures (Figure S1B available online). However,
STAT6-deficient Th2 cells displayed reduced phospho-STAT3
during the last 2 days of differentiation, suggesting that genes
downstream of STAT6 were at least partially responsible for
maintaining STAT3 phosphorylation (Figure S1B). Similar
patterns of pSTAT6 and pSTAT3 are observed in Th2 cell
cultures of DO11.10 TCR transgenic T cells stimulated with
anti-CD3 or ovalbumin (Figures 1C and 1D), although with
antigen stimulation, pSTAT6 rose more slowly at culture initia-
tion, and pSTAT3 decreased more dramatically at the end of
culture. Taken together these data show that STAT3 becomes
phosphorylated during Th2 cell differentiation.
STAT3-Deficient Cells Are Defective
in Th2 Cell Differentiation
To determine which cytokines were activating STAT3 during Th2
cell differentiation, we cultured Th2 cells in the presence of
antibodies to cytokines known to activate STAT3. A combination
of anti-IL-2 and anti-CD25 decreased Th2 cytokine production
coincident with a decrease in pSTAT5 (Figure 2A and data not
shown), similar to previous results (Cote-Sierra et al., 2004).
Antibodies to IL-6 or IL-21 decreased IL-4 and IL-13 production,
although they had no effect on IL-5 production (Figure 2A).
Although the individual antibodies did not have a substantial
effect on pSTAT3, a combination of antibodies to IL-2, CD25,
IL-6, and IL-21 decreased pSTAT3, as well as pSTAT5, without
affecting pSTAT6 (Figure 2B and data not shown). Thus, several
cytokines play redundant roles in the activation of STAT3 during
Th2 cell differentiation.
To specifically define whether the activation of STAT3 during
Th2 cell development reflected a requirement for STAT3 in this
process, we used mice that have a floxed Stat3 allele, mated40 Immunity 34, 39–49, January 28, 2011 ª2011 Elsevier Inc.to mice expressing Cre from a Cd4 transgene (referred to as
Stat3Cd4/ mice). As previously described, T cell development
in mice with STAT3-deficient T cells is undistinguishable from
wild-type mice (Mathur et al., 2007). Moreover, growth, prolifer-
ation, and apoptosis of STAT3-deficient Th2 cells were not
obviously different from wild-type cultures (Figures S2A–S2C).
Importantly, STAT6 phosphorylation was not dependent on
STAT3; a similar pattern was observed in STAT3-deficient
cultures (Figures 1A and 1B). To examine differentiation, naive
CD4+ T cells were isolated from spleens of wild-type and
Stat3Cd4/ mice and cultured under Th1, Th2, or Th17 cell
conditions. STAT3-deficient Th1 cells produced similar amounts
of the cytokines IFN-g and GM-CSF as did wild-type Th1 cells,
although STAT3 was required for the generation of cells
secreting IL-17A and IL-17F (Figure S2D). Although wild-type
Th2 cells secreted high amounts of IL-4, IL-5, and IL-13,
STAT3-deficient CD4+ T cells cultured under Th2 cell-skewing
conditions had diminished IL-4, IL-5, and IL-13 production and
gene expression and also diminished expression of the gene en-
coding the Th2 cell-associated cytokine IL-24 (Figures 2C–2E).
STAT3-deficient Th2 cells had only a modest increase in IFN-g
production, suggesting that they were not differentiating into
Th1 cells and did not acquire expression of Foxp3 mRNA (Fig-
ure S2E and data not shown).
STAT3 Is Required for Th2 Cell Transcription
Factor Expression
Previous studies have demonstrated that STAT3-deficient CD4+
cells have reduced CD25 expression (Akaishi et al., 1998) and
IL-2 signaling is required for Th2 cell differentiation at multiple
levels including the expression of Il4ra (Liao et al., 2008).
To determine whether CD25 or IL-4Ra expression was
decreased on STAT3-deficient cells during Th2 cell differentia-
tion, we examined surface expression throughout differentiation.
The percent of receptor-positive cells was comparable between
wild-type and STAT3-deficient Th2 cells (Figure S3), and
although the MFI of CD25 was decreased on the fourth day of
differentiation, adding exogenous IL-2 during differentiation did
not rescue Th2 cytokine production in STAT3-deficient cultures
(data not shown). Normal IL-4Ra expression in STAT3-deficient
Th2 cell cultures was consistent with normal STAT6 activation
in the absence of STAT3 (Figures 1A and 1B). These data
suggest that the reduction in Th2 cytokine production in
STAT3-deficient Th2 cells is not due to reduced CD25 or
IL-4Ra expression.
We then examined the expression of transcription factors
associated with establishing the Th2 cell phenotype including
Gata3, Batf, Maf, Gfi1, Irf4, and the IL-6 target Socs1 during
the differentiation process. Expression of Gata3 was decreased
throughout differentiation; Maf and Batf expression were more
affected during the last 3 days of differentiation (Figure 3A).
GATA3 protein was also decreased 24 hr after the initiation of
culture, but endogenous IL-2 or IL-4 production was not affected
by STAT3 deficiency at this time point (Figures S4A and S4B and
data not shown). Gfi1 and Irf4 expression were less affected by
STAT3 deficiency, and Socs1 expression was decreased only
during the last 3 days of differentiation (Figure S4C), agreeing
with our data that IFN-g was not induced in STAT3-deficient
Th2 cell cultures (Diehl et al., 2000). The expression of Gata3,
Figure 1. STAT3 Is Activated during Th2 Cell Differentiation
(A) Wild-type (WT) and Stat3Cd4/ naive CD4+ T cells were activated with anti-CD3 and anti-CD28 and cultured in IL-4 and anti-IFN-g (Th2 cell conditions). Each
day during differentiation, cells were stained for intracellular phospho-STAT3 and phospho-STAT6. Numbers in flow cytometry dot plots indicate the percentages
of cells in each quadrant.
(B) Graphical representation of percent phospo-STAT-positive cells and mean fluorescent intensity (mean ± SD). Data are an average of two mice and are repre-
sentative of two to three experiments.
(C) Naive DO11.10 TCR transgenic T cells were stimulated with anti-CD3 or ovalbumin (OVA) in the presence of antigen-presenting cells and cultured under Th2
cell conditions. Each day during differentiation, cells were stained for intracellular phospho-STAT3 and phospho-STAT6. Numbers in flow cytometry dot plots
indicate the percentages of cells in each quadrant.
(D) Graphical representation of average percent phospho-STAT-positive cells for DO11.10 TCR transgenic T cells stimulated with OVA or anti-CD3 (mean ± SD).
Data are an average of two mice and are representative of two experiments.
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Figure 2. Reduced Th2 Cytokine Production in the Absence of STAT3
(A) WT naive CD4+ T cells were activated with anti-CD3 and anti-CD28 and cultured under Th2 cell conditions, in the presence or absence of antibodies to the
indicated cytokines and receptors (20 mg/ml per antibody) for 5 days before stimulation with anti-CD3. 24 hr after stimulation supernatants were tested for cyto-
kine concentration via ELISA (mean ± SD). Results are representative of experiments with four mice.
(B) Cells cultured as in (A) with control antibody or the combination of antibodies indicated were tested for amount of pSTAT by intracellular staining on day 4 of
Th2 cell culture. Numbers represent mean fluorescence intensity. Results are representative of experiments with four mice.
(C) WT and Stat3Cd4/ naive CD4+ T cells were activated with anti-CD3 and anti-CD28 and cultured with IL-4 + anti-IFN-g (Th2 cell conditions). After 5 days of
differentiation, cells were collected and counted. Differentiated cells (13 106) were then restimulated with anti-CD3 (4 mg/ml) for 24 hr. Cell-free supernatant was
collected and tested for various cytokines via ELISA. Data are themean ± SDof results from twomice and representative ofmore than five experiments. Student’s
t test was performed to calculate p values.
(D) Cells activated and cultured as in (A) were restimulated with anti-CD3 for 5 hr. After stimulation, cells were stained with anti-IL-4 and anti-IL-9. Numbers in flow
cytometry dot plots indicate the percentages of cells in the quadrant.
(E) After restimulation of differentiated Th2 cells with anti-CD3 and recovery of supernatants as described in (A), cell pellets were collected, RNAwas isolated, and
quantitative PCR was performed for the indicated cytokines (mean ± SD). Data are representative of two experiments.
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STAT3 in Th2 CellsMaf, Batf, and Irf4 is also decreased at day 5 of differentiation
(Figure 3A; Figure S4D). The loss of Gata3 and Maf expression
in STAT6-deficient Th2 cells was greater than in STAT3-deficient
Th2 cells. However, STAT3 but not STAT6 was required for
optimal Irf4 expression (Figures S4D and S1C).
To further define the effects of STAT3 deficiency on the loci
most affected, we examined the presence of histone modifica-42 Immunity 34, 39–49, January 28, 2011 ª2011 Elsevier Inc.tions trimethyl-H3K4 and -H3K36 that are associated with
active genes, and trimethyl-H3K27, which is associated with
repressed genes, at the Gata3, Batf, andMaf loci. In naive cells,
there was either an increased or unchanged amount of tri-
methyl-H3K4 and -H3K36, suggesting that STAT3 was not
required for these modifications in unstimulated cells (Fig-
ure 3B). In contrast, there was a marked increase in H3K27
Figure 3. Reduced Th2 Cell-Specific Tran-
scription Factor Expression in the Absence
of STAT3
(A) WT and Stat3Cd4/ naive CD4+ T cells were
differentiated under Th2 cell conditions and cells
were isolated each day during differentiation.
RNA isolated from cells was analyzed for gene
expression with qPCR (mean ± SD). Data are
representative of experiments with four mice.
(B) WT and Stat3Cd4/ naive CD4+ T cells were
used directly or differentiated as in (A) for 5 days.
Chromatin immunoprecipitation was performed
for the indicated histone modifications and qPCR
was used to determine the amounts of each modi-
fication (mean ± SD).
(C) Chromatin immunoprecipitation fromWT naive
CD4+ T cells with control or STAT3 antibodies fol-
lowed by qPCR for detection of the indicated loci
(mean ± SD).
(D) WT and Stat3Cd4/ naive CD4+ T cells were
differentiated as in (A) for 5 days. Nuclei were iso-
lated and left untreated or treated with micro-
coccal nuclease for 10 min. Relative accessibility
is defined as 2 to the power of the difference
between the Ct value of qPCR of untreated and
treated samples (mean ± SD).
(E) WT and Stat3Cd4/ naive CD4+ T cells were
differentiated as in (A). On day 2, cells were trans-
duced with control,Batf-, orMaf-expressing retro-
virus. Sorted transduced cells were restimulated
with anti-CD3 for 24 hr. Supernatant was tested
for Th2 cytokines with ELISA (mean ± SD). Data
are representative of two independent experi-
ments.
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STAT3 in Th2 Cellstrimethylation in naive STAT3-deficient T cells (Figure 3B), sug-
gesting that STAT3 plays a role in preventing this modification,
and correlating with STAT3 bound to these loci in naive cells
(Figure 3C). In contrast, differences in H3K27 methylation
between wild-type and STAT3-deficient Th2 cells were not
observed. The Gata3 and Batf loci did not have decreased
H3K4 and H3K36 methylation in STAT3-deficient Th2 cells
compared to wild-type Th2 cells. However, activating histone
modifications were decreased at the Maf locus (Figure 3B). To
determine whether STAT3 was also affecting the accessibility
of chromatin, we performed micrococcal nuclease assays with
nuclei from wild-type and STAT3-deficient Th2 cells. We
observed decreased accessibility at all three loci, with the great-
est difference at the Batf locus (Figure 3D).
We then tested whether transduction of any of these factors
into STAT3-deficient Th2 cell cultures would result in a recovery
of cytokine production. Although transduction of Gata3 into
STAT3-deficient Th2 cells did not alter cytokine production
(data not shown), transduction of either Maf or Batf resulted in
a partial recovery of Th2 cytokine production, with Maf having
the greatest effects on IL-4 production (Figure 3E). Thus, Maf
andBatf probably represent STAT3 targets during Th2 cell devel-
opment, and the defects in Th2 cytokine production in the
absence of STAT3 are the result of effects on multiple down-
stream transcription factors.STAT3 and STAT6 Cooperate in Promoting Th2 Cell
Cytokine Production
To determine whether STAT6 and STAT3 are cooperating to
promote Th2 cytokine production, we used two previously
described constitutively active STAT mutants. Both the
STAT6VT and STAT3C have two amino acid mutations within
the SH2 domain, which renders them constitutively active in
the absence of a stimulus (Bromberg et al., 1999; Bruns et al.,
2003). We first transduced STAT3C into naive CD4+ T cells acti-
vated under nonskewing conditions (anti-IFN-g), which has
previously been shown to increase IL-17 production (Mathur
et al., 2007). Under nonskewing conditions, transduction of
STAT3C induced the production of Th2 cytokines (Figure 4A).
To directly test whether the combination of constitutively
active STAT6 and STAT3 could increase Th2 cytokine produc-
tion compared to constitutively STAT6 alone, naive T cells
cultured under Th1 cell conditions were transduced with retrovi-
ruses expressing STAT6VT and STAT3C alone or in combina-
tion. Under these conditions, STAT3C alone did not increase
IL-4 production, had modest effects on IFNg production, and
did not induce IL-17 production (Figure 4B and data not shown).
Transduction of STAT6VT increased IL-4 production and
decreased IFN-g, and cotransduction of STAT3C further
increased the amount of IL-4 produced in these cultures
(Figure 4B).Immunity 34, 39–49, January 28, 2011 ª2011 Elsevier Inc. 43
Figure 4. STAT3 and STAT6 Cooperate in
Promoting Th2 Cytokine Production
(A) Naive CD4+ T cells were activated for 48 hr in
the absence of skewing cytokines before being
transduced with control or STAT3C-expressing
retrovirus. After 5 days in culture, cells were sorted
and restimulated with anti-CD3 (4 mg/ml) for 24 hr
before cell-free supernatant was tested for cyto-
kines via ELISA (mean ± SD).
(B)NaiveCD4+Tcellswere activated for 48hrunder
Th1 cell conditions (5 ng/ml IL-12 + 10 mg/ml anti-
IL-4) before being transduced with control,
STAT6VT-expressing, STAT3-expressing, or both
retroviruses. After 5 days in culture, cells were
sorted and restimulated with anti-CD3 (4 mg/ml) for
24 hr before cell-free supernatant was tested for
cytokines with ELISA (mean ± SD).
(C) CD4+ cells were isolated from WT, STAT6VT,
andSTAT6VT-Stat3Cd4/mice.Cellswere then re-
stimulated with anti-CD3 for 24 hr. Cell-free super-
natant was collected and tested for various cyto-
kines via ELISA. Data are representative of two
experiments (average of 2–6 mice ± SD). Student’s
t test was performed to calculate p values.
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STAT3 in Th2 CellsWe then wanted to confirm the requirement for STAT3 for
optimal Th2 cell differentiation in vivo in the presence of a consti-
tutively active STAT6. Peripheral T cells in STAT6VT transgenic
mice have an increased propensity toward a Th2 cytokine-
secreting phenotype (Bruns et al., 2003; Sehra et al., 2008). To
directly test whether STAT3 is necessary for Th2 cytokine
production in this in vivo system, we isolated CD4+ T cells from
the spleens of wild-type, STAT6VT transgenic, and STAT6VT
transgenic crossed to Stat3Cd4/ (STAT6VT-Stat3Cd4/)
mice, and stimulated cells with anti-CD3 for 24 hr before cyto-
kine production was assessed with ELISA. As shown previously,
STAT6VT mice have increased production of IL-4, IL-5, and IL-
13, whereas STAT6VT T cells lacking STAT3 produced Th2 cyto-
kines in amounts similar to wild-type cells (Figure 4C). These
results demonstrate that STAT3 cooperates with STAT6 to
promote Th2 cytokine production.STAT3 Binds Th2 Cell-Associated Gene Loci
and Defines the STAT6 Binding Pattern
To further examine the cooperation of STAT6 and STAT3 in
enhancing Th2 cytokine production, binding of these proteins
to gene targets was determined via chromatin immunoprecipita-
tion. In Th2 cells, similar to binding in naive T cells (Figure 3C),
STAT3 directly binds a number of the same loci bound in Th17
cells, including Maf, Batf, and Irf4, which also contribute to
Th17 cell development (Bauquet et al., 2009; Betz et al., 2010;
Brustle et al., 2007; Schraml et al., 2009). STAT3 was also bound
to Gata3 and Il21, a cytokine produced by multiple Th cell
subsets, but was more prominent at the Il17 and Il17f loci in
Th17 cells than in other Th cell subsets (Figure 5A).
We then tested whether STAT3 has an effect on STAT6
binding to target genes. In Th2 cells, STAT6 binds to the
Gata3, Maf, Batf, and Irf4 genes (Figure 5B). However, in the
absence of STAT3, STAT6 binding was either undetectable or
greatly diminished (Figure 5B). This was concurrent with
decreased locus accessibility in the absence of STAT3 (Fig-44 Immunity 34, 39–49, January 28, 2011 ª2011 Elsevier Inc.ure 3D) and suggests that STAT3 is required to allow access
for STAT6 to bind these loci and increase gene expression.
We then tested whether an active STAT6 was capable of
inducing expression of Th2 cell transcription factors in the
absence of STAT3. Expression of Gata3 and Maf were signifi-
cantly increased in STAT6VT CD4+ T cells examined directly
ex vivo, compared to cells from wild-type mice. However,
STAT3-deficient STAT6VT CD4+ T cells had reduced expression
of bothGata3 andMaf, compared to T cells from STAT6VT trans-
genic mice on a wild-type background (Figure 5C). Together,
these data suggest that STAT3 facilitates the ability of STAT6
to bind target genes and promote the Th2 cell genetic program.STAT3 in T Cells Is Required for the Development
of Allergic Inflammation
To test whether STAT3 is also required for in vivo Th2 cell differ-
entiation, wild-type and Stat3Cd4/ mice were sensitized with
alum-adsorbed OVA. Twoweeks after the second immunization,
and after intranasal challenges, we observed that pulmonary
inflammation, assessed by total cell number and by number of
eosinophils in the bronchoalveolar lavage (BAL), was decreased
in Stat3Cd4/ mice, compared to wild-type mice (Figure 6A).
Amounts of Th17 and Th2 cytokines were decreased in the
BAL fluid and in cultures of splenocytes stimulated in vitro with
OVA analyzed via ELISA (Figures 6B and 6C). Although Th2
cell immunity is clearly decreased in vivo, the simultaneous
requirement for Th17 cells in this model (Lewkowich et al.,
2005; Schnyder-Candrian et al., 2006) complicates the interpre-
tation of the requirement for STAT3-dependent Th2 cell-medi-
ated inflammation in vivo.
To investigate the requirement for STAT3 in allergic inflamma-
tion further, we used mice expressing STAT6VT in T cells that
spontaneously develop multiorgan allergic inflammation,
including pulmonary inflammation, blepharitis, and skin inflam-
mation, all of which are completely dependent on IL-4 (Sehra
et al., 2008, 2010). The incidence of blepharitis in STAT6VT
Figure 5. STAT3 Binds Th2 Cell-Associated
Gene Loci and Defines the STAT6 Binding
Pattern
(A) Naive CD4+ T cells activated with anti-CD3 and
anti-CD28 and cultured under Th1, Th2, or Th17
cell conditions for 3 days were used for ChIP per-
formed with normal rabbit IgG or anti-STAT3
before qPCR was performed for the indicated
genes. Data are expressed as percent input ±
SD and control Ig background values are sub-
tracted from the values indicated. Data are repre-
sentative of three to four experiments with similar
results.
(B) Naive CD4+ T cells from WT and Stat3Cd4/
activated with anti-CD3 and anti-CD28 and
cultured under Th2 cell conditions for 3 days
were used for ChIP performed with normal rabbit
IgG or anti-STAT6 and qPCR was performed for
the indicated genes. Data are expressed as
percent input ± SD and control Ig background
values are subtracted from the values indicated.
Data are representative of three to four experi-
ments with similar results. ND, not detected.
(C) CD4+ cells were isolated from WT, STAT6VT,
and STAT6VT-Stat3Cd4/ mice. Cells were then
restimulated with anti-CD3 for 6 hr before RNA
was isolated and quantitative PCR was per-
formed. Data are representative of two experi-
ments (average of 2–6 mice ± SD). Student’s
t test was performed to calculate p values.
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STAT3 in Th2 Cellsmice is nearly 75% and is never observed in wild-type mice.
STAT6VT-Stat3Cd4/ mice were protected from blepharitis
and have 0% incidence even in older mice (Figure 6D). Approx-
imately 40%of STAT6VT transgenic mice developed skin inflam-
mation resembling atopic dermatitis, a condition not observed in
wild-type mice. As with blepharitis, STAT6VT transgenic mice
lacking STAT3 in T cells were protected from skin inflammation,
thickening of the skin, and immune infiltration (Figures 6D and
6F). STAT6VT transgenic mice develop lung inflammation char-
acterized by peri-bronchial and peri-arterial accumulation of
eosinophils and lymphocytes. However, STAT6VT-Stat3Cd4/
mice, like wild-type mice, had very few eosinophils infiltrating
the lungs (Figures 6E and 6G). These results demonstrate that
the loss of STAT3 in T cells protects mice from the development
of Th2 cell-mediated inflammatory diseases. Taken together,
STAT3 and STAT6 proteins are both necessary for optimal Th2
cell development, and in the context of the STAT6 signal,
STAT3 enhances Th2 cell development.
DISCUSSION
The paradigm that STAT family members promoted specific Th
effector cell phenotypes was developed when the number of
known effector subsets was more limited. We and other
researchers initially defined that STAT4 is required for Th1 cell
development, and STAT6 is required for Th2 cell development
(Kaplan et al., 1996a, 1996b; Shimoda et al., 1996; Takeda
et al., 1996; Thierfelder et al., 1996). However, this simple oneSTAT-one subset paradigm became more complicated when it
was shown that STAT1 also contributed to Th1 cell differentiation
(Afkarian et al., 2002; Lighvani et al., 2001), and STAT5 could
function with STAT6 in the development of Th2 cells (Cote-Sierra
et al., 2004; Takatori et al., 2005; Zhu et al., 2003). This was an
important finding because STAT5, which is also critical for the
development of T regulatory cells (Burchill et al., 2007; Yao
et al., 2007), has different functions when activated in the pres-
ence of STAT6. Thus, the differentiating T helper cell is able to
assimilate multiple signals and acquire the appropriate effector
phenotype. In this report, we further our understanding of the
integration of STAT signals by demonstrating that STAT3, which
clearly promotes Th17 cell development in the absence of
signals that promote other phenotypes, is required for the func-
tion of STAT6 during Th2 cell development.
Based on our data, we propose the following model of Th2 cell
development. STAT3 is bound to multiple Th2 cell-associated
transcription factor loci even in naive cells, which limits repres-
sive histone modifications. Upon activation in a pro-Th2 cell
environment, STAT3 is activated by multiple cytokines
promoting chromatin remodeling and allowing STAT6 to bind
and activate target genes. STAT3 also has direct effects on
histone modifications at the Maf locus. Interestingly, we find
that H3K4 methylation is STAT3 dependent at the Maf but not
the Batf locus, whereas in Th17 cells the opposite pattern was
observed (Durant et al., 2010). The similarity in STAT3 target
genes in Th2 and Th17 cells suggests that STAT3 is able to
initiate differentiation to both phenotypes, and it is the presenceImmunity 34, 39–49, January 28, 2011 ª2011 Elsevier Inc. 45
Figure 6. STAT3 Promotes the Development of Allergic Inflammation
(A–C) WT and Stat3Cd4/mice were immunized with OVA and Alum on days 0 and 7 and challenged as described in Experimental Procedures. After challenges,
BAL cell numbers were determined by cell counting and flow cytometry (A), and cytokine levels were measured in BAL fluid and in culture supernatants from
splenocytes stimulated with OVA for 72 hr via ELISA. Data are average of 5–6 mice per group ± SEM.
(D) Incidence of blepharitis and atopic dermatitis ofWT, STAT6VT, and STAT6VT-Stat3Cd4/mice are shown. Incidencewas determined by visual examination of
mice (n = 25 per group).
(E) Numbers of eosinophils (defined by flow cytometry) recovered in BAL. BAL data are representative of two independent experiments and shown as the average
of two mice per group ± SD. For (A)–(C) and (E), Student’s t test was performed to calculate p values.
(F) Ear tissue from WT, STAT6VT, and STAT6VT-Stat3Cd4/mice were fixed and paraffin-embedded sections were stained with hematoxylin-eosin. Magnifica-
tion is indicated in the panel and photomicrographs are representative of 10 mice per group.
(G) Lungs from WT, STAT6VT, and STAT6VT-Stat3Cd4/ mice were embedded in paraffin and stained with H&E. Magnification is indicated in the panel and
photomicrographs are representative of 10 mice per group.
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STAT3 in Th2 Cellsof the IL-4/STAT6 signal that promotes Th2 cell development at
the expense of the Th17 cell program. IL-4 signaling has a similar
effect on Treg cell development by decreasing STAT5 binding to
the Foxp3 locus (O’Malley et al., 2009) and promoting an alterna-
tive T helper cell subset. Thus, STAT6 plays a definitive role in the
outcome of Th cell differentiation in the presence of IL-4.
The exact targets of STAT3 required for Th2 cell development
are not entirely clear and probably several targets are important.
Although theMaf gene is a characterized target of STAT3 (Yang
et al., 2005) and expression of Maf is deficient in the absence of
STAT3, ectopic expression of Maf resulted in only a partial
recovery of Th2 cytokine production. BATF, a transcription factor
recently shown to promote Th2 cell development, also requires
STAT3 for normal expression in Th2 cells, and transduction of
Batf resulted in a partial recovery of Th2 cytokine production.
We did not see recovery of Th2 cytokine production when
Gata3 or Irf4 were ectopically expressed. This is distinct from
STAT6-deficient cells where expression of GATA3 induces Th246 Immunity 34, 39–49, January 28, 2011 ª2011 Elsevier Inc.cytokine production (Chang et al., 2005; Ouyang et al., 2000).
Together these data suggest that the defect in STAT3-deficient
Th2 cell cultures is more complex than the absence of one factor
and recovery of Th2 cytokine expression may require the coordi-
nated function of several factors.
The requirement for STAT3 in Th2 cell development is in
contrast to the hyper-IgE syndrome that develops in patients
with dominant-negative STAT3mutations (Ma et al., 2008; Milner
et al., 2008). Although human STAT3 mutations are autosomal
dominant, it is reasonable to expect that some STAT3 function
is retained in these patients because, at least in mice, STAT3
deficiency is embryonic lethal (Takeda et al., 1997). Moreover,
it is yet unclear how STAT3 mutants result in hyper-IgE
syndrome. Like mice with STAT3-deficient T cells (Mathur
et al., 2007; Yang et al., 2007), patients with hyper-IgE syndrome
lack Th17 cells, though effects on Th2 cells in patients have not
been clearly defined. However, mice with STAT3-deficient
T cells do not have increased serum IgE (data not shown),
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STAT3 in Th2 Cellssuggesting either that human STAT3mutants are not functionally
equivalent to STAT3 deficiency or that mutant STAT3 promotes
hyper-IgE in cells other than T cells. Although mutant STAT3 in
human B cells is required for IL-21-stimulated IgE production
and generation of memory B and plasma cells, STAT3 deficiency
in mouse B cells affects IgG responses but does not result in
hyper-IgE syndrome (Avery et al., 2008, 2010; Fornek et al.,
2006). The pathogenesis of hyper-IgE syndrome is clearly
complex and additional mechanistic insight into STAT3-depen-
dent functions probably requires introduction of STAT3 muta-
tions into a mouse model.
Multiple signals contribute to the generation of differentiated
T helper cell subsets. However, in this model there is a dominant
signal, IL-4 in the case of Th2 cells, which defines the outcome of
the differentiation process. It is clear that STAT3 is required for
the development of Th17 cells and that constitutively active
STAT3 promotes the development of IL-17-secreting cells (Ma
et al., 2008; Mathur et al., 2007; Milner et al., 2008; Nurieva
et al., 2008; Yang et al., 2005, 2007). However, IL-4 provides
a dominant signal that diminishes Th17 cell development (Har-
rington et al., 2005; Park et al., 2005) and decreases symptoms
of autoimmunity in multiple models (Rocken et al., 1996). Thus,
when both STAT3 and STAT6 signals are present in a cell, the
pro-Th17 cell effects of STAT3 are reduced, whereas the pro-
Th2 effects of STAT6 are amplified. Mechanistically this occurs
through the binding of STAT3 to Th2 cell genes that facilitate
the ability of STAT6 to activate genes necessary for Th2 cell
development. Thus, multiple STAT proteins, activated by cyto-
kines present in the milieu of a developing immune response,
cooperate in defining the ultimate phenotype of the differenti-
ating effector T cell.
EXPERIMENTAL PROCEDURES
Mice
Stat3fl/fl mice (Chiarle et al., 2005) with a Cd4-Cre (Stat3Cd4/) transgene and
wild-type mice (Harlan Laboratories, Indianapolis, IN) were on a C57BL/6
background. WT mice in experiments with Stat3Cd4/ mice were Cre-nega-
tive littermates. STAT6VT (STAT6 with V547 and T548 mutated to alanine)
transgenic mice, previously described (Bruns et al., 2003), were backcrossed
to C57BL/6 mice (Harlan Laboratories). Stat3Cd4/ mice were mated to
STAT6VT transgenic mice to generate STAT6VT-Stat3Cd4/ mice. All mice
were maintained in specific-pathogen-free conditions and experiments were
approved by the Indiana University Institutional Animal Care and Use
Committee.
Quantitative RT-PCR
Total RNA was isolated from either unstimulated or anti-CD3 (2 mg/ml)-re-
stimulated cells with Trizol and reverse transcribed according to manufac-
turer’s instructions (Invitrogen Life Technologies, Carlsbad, CA). Quantitative
PCR was performed with Taqman Fast Universal PCR Master Mix and
commercially available primers for genes with the 7500 Fast Real-Time PCR
system (Applied Biosystems, Foster City, CA). RNA was normalized to expres-
sion levels of b2-microglobulin and relative expression was calculated with the
2-DDCt method.
Murine T Helper Cell Differentiation
Naive CD4+CD62L+ T cells were purified from spleens via magnetic isolation
(Miltenyi Biotec, Auburn, CA). Naive CD4+ T cells (13 106 cells/ml of complete
RPMI-1640 medium) were cultured with plate-bound anti-CD3 (4 mg/ml 145–
2C11) and soluble anti-CD28 (1 mg/ml; BD PharMingen) under Th2 cell (IL-4
at 10 ng/ml [PeproTech, Rocky Hill, NJ] and anti-IFN-g at 10 mg/ml), Th1 cell
with anti-IL-4 (10 mg/ml 11B11) and IL-12 (5 ng/ml; R&D Systems), or Th17cell with anti-IFN-g, anti-IL-4, TGF-b1 (2 ng/ml; R&D Systems), and IL-6
(100 ng/ml; PeproTech). Cells were expanded on day 3 after stimulation by
adding half the dose of the original cytokines in fresh medium. After 5 days
of culture, differentiated cells were restimulated with plate-bound anti-CD3
at 4 mg/ml for 1 or 3 days, and the cell-free supernatant was collected after
centrifugation and stored at20C until use. The levels of cytokines produced
were determined via ELISA (reagents from BD PharMingen or eBioscience).
For cytokine-blocking experiments, Th2 cells were cultured as above in the
presence of control antibody or blocking antibodies to IL-2, IL-6, IL-21, and/
or CD25 (20 mg/ml, BD PharMingen or R&D Systems) from the initiation of
culture and additional antibodies added at day 3 during cell expansion. Naive
CD4+ T cells from DO11.10 mice were stimulated with plate-bound anti-CD3
and anti-CD28, or 100 mg/ml OVA protein and anti-CD28, and cultured with
anti-IFN-g and IL-4 and CD4-depleted irradiated APCs (1:5). On day 3 of
culture, cells were expanded and an additional dose of IL-4 was added.
Retroviral Transduction
Bicistronic retroviral vectors encoding mouse GATA3 or IRF4 and human CD4
(Ahyi et al., 2009; Chang et al., 2005), STAT6VT or c-MAF (kindly provided by
I.C. Ho) and EGFP, or STAT3C (Mathur et al., 2007) or BATF (Williams et al.,
2003) subcloned into the bicistronic retroviral vector containing the marker
Thy1.1 and Thy1.1 empty vector (kindly provided by S. Goenka) were used
to generate virus as described (Mathur et al., 2007). After 2 days of differenti-
ation, T helper cells were transduced with retroviral supernatant containing
polybrene. On day 5, transduced cells (EGFP-, Thy1.1-, or hCD4-positive cells)
were sorted by flow cytometry before cytokine production and gene expres-
sion analyses.
Analysis of Inflammation and Th2 Cell Responses In Vivo
Immunization and challenge of mice was performed as described (Chang
et al., 2010; O’Malley et al., 2009). Splenocytes from the mice were stimulated
with OVA (100 mg/ml) for 72 hr and Th2 cytokines in cell-free supernatants were
assessed via ELISA. Paraffin-embedded sections were stained with hemat-
oxylin and eosin for evaluation of the infiltration of inflammatory cells by light
microscopy. BAL was performed and eosinophils in the BAL were identified
as described (Chang et al., 2010; O’Malley et al., 2009).
Intracellular Staining
After differentiation, cells were restimulated with anti-CD3 (4 mg/ml) for 5 hr.
Monensin was added to the cells for the final 2 hr of stimulation. After stimula-
tion, cells were fixed with paraformaldehyde and permeablized with saponin.
Cells were then stained with fluorochrome-conjugated anti-mouse IL-4
(BVD6-24G2; eBioscience). For intracellular phospho-STAT staining, T cells
were collected and fixed with 1.5% formaldehyde for 10 min at room temper-
ature. After fixation, cells were permeabilized for 15 min at 4C with 100%
methanol. Cells were then stained for phospho-STAT3 or phospho-STAT6
(BD PharMingen) for 30 min at room temperature. Cells were analyzed by
flow cytometry with FACSCalibur (Beckton Dickinson) and results were
analyzed with WinMDI.
Chromatin Immunoprecipitation
ChIP assay was performed as previously described (Yu et al., 2007). Immuno-
precipitations were performed with rabbit polyclonal antibodies (anti-STAT3
sc-482, anti-Stat6 sc-1698, rabbit IgG [Santa Cruz], H3K4me3, and
M3K27me3 [Millipore], H3K36me3 [Abcam]). Quantification of DNA was per-
formed with SYBR Green Fast PCR Master Mix (primer sequences provided
in Table S1) via ABI 7500 Fast Real-time PCR System. To quantify immunopre-
cipitated DNA, a standard curve was generated from serial dilutions of input
DNA. To calculate ChIP results as a percentage of input, the amount of the
immunoprecipitated DNA from the IgG control was subtracted from the
amount of the immunoprecipitated DNA from the specific antibody ChIP
followed by normalizing against the amount of the input DNA.
Nuclease Accessibility Assay
Nuclei were isolated from naive CD4+ T cells or Th2 cells by using preparation
buffer (0.3 M sucrose, 60 mM KCl, 0.1 mM ethylene glycol tetraacetic acid
[EGTA], 15 mM Tris-HCl [pH 7.5], 15 mM NaCl, and 5 mM MgCl2) containing
0.4% NP-40. Nuclei were pelleted by centrifugation at 200 rpm for 5 minImmunity 34, 39–49, January 28, 2011 ª2011 Elsevier Inc. 47
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protease inhibitors before samples were stored in preparation buffer at
80C. Aliquots of nuclei (1 3 106) were incubated with 0.2 U of micrococcal
nuclease S7 (MNase) (Roche) in MNase digestion buffer (60 mM KCl, 15 mM
Tris-HCl [pH 7.5], 15 mM NaCl, and 1 mM MgCl2, 0.5 mM Spermidine,
0.1 mM PMSF) containing 5 mM CaCl2 and protease inhibitor cocktail for
10 min at 37C, and the reactions were terminated by the addition of stop
buffer (20 mM EDTA, 1% SDS, and 100 mg/ml proteinase K). Genomic DNA
was then purifiedwith the high pure PCR product purification kit (Roche). Rela-
tive accessibility was quantified with SYBR Green Fast PCR Master with ABI
7500 Fast Real-time PCR System. Relative accessibility is defined as 2 to
the power of the difference between the Ct value of qPCR of nuclease
untreated and treated samples.SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures and one table and can be
found with this article online at doi:10.1016/j.immuni.2010.12.013.
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